VKTX
Viking Therapeutics Inc.
Company Overview
| Mkt Cap | $3.95B | Price | $38.08 |
| Volume | 3.60M | Change | -0.24% |
| P/E Ratio | -35.9 | Open | $38.50 |
| Revenue | -- | Prev Close | $38.17 |
| Net Income | $-110.0M | 52W Range | $18.92 - $79.10 |
| Div Yield | N/A | Target | $88.56 |
| Overall | 57 | Value | 60 |
| Quality | 47 | Technical | 66 |
No chart data available
Stock Overview
Updated DailyViking Therapeutics Inc. (VKTX) is a leading Healthcare company in the Biotechnology industry, currently trading at $38.08 with a market capitalization of $3.95 billion. The stock is in the lower portion of its trading range, demonstrating below-average quality metrics with a MarketXLS quality score of 47.
Today's trading session shows VKTX with a volume of 3.60 million shares. The stock opened up 0.86% from yesterday's close of $38.17. Current analyst estimates project earnings of $-2.67 per share for this year, with next year targeting $-3.61.
VKTX demonstrates positive technical signals based on technical analysis. The company trades on the NSC exchange and operates alongside industry peers including RGEN, ENZN, SNGX, GERN.
Key investment considerations for VKTX include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 132.6%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 11:16 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VKTX | $38.08 | -0.2% | 3.60M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Viking Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW